Eligo Bioscience

🔥 Another new opening at Eligo to work on CRISPR and Engineered Phages to cure microbiome-associated diseases

👩🏽‍🔬👨‍🔬 Join a fantastic teams of genetic engineers from all over the world in the center of Paris 🇫🇷

Careers | Research Associate Microbiology & Genetic Engineering - Eligo Bioscience Research Associate Microbiology & Genetic Engineering PARIS, FRANCE          FULL-TIME Eligo is a six-year-old biotechnology startup, spun out of MIT and Rockefeller University, and based in Paris, France. Eligo has raised more than 20 million euros from leading investors in Silicon Valley and ...

An exciting position with a transversal and panoramic view on both corporate finances and business operations to support Eligo on strategic topics!

If you thrive in fast-paced environments with cutting-edge science and are excited to solve real-world problems, this job is for you!

Careers | BD Associate - Eligo Bioscience Business Development Associate PARIS, FRANCE          FULL-TIME Eligo is a six-year-old biotechnology startup, spun out of MIT and Rockefeller University, and based in Paris, France. Eligo has raised more than 20 million euros from leading investors in Silicon Valley and France to develop next-...

[EXCITING OPPORTUNITY] - Eligo Bioscience is looking to hire a Head of Operations to join our international team of passionate Eligonauts as we prepare for a rapid scale-up! 🚀🧬💊

Eligo is developing innovative genetic engineering technologies to cure disease, and we look forward to growing our team! This is an opportunity to work in a fast-paced environment for a mission-driven company.

https://eligo.bio/ops/

Eligo Bioscience | Careers - Head of Operations Eligo Bioscience | Careers - Head of Operations

Eligo Bioscience in the New York Times!

Is Crispr the Next Antibiotic? In nature, the gene-editing tool Crispr protects bacteria against viruses. Now it’s being harnessed in the fight against superbugs and the flu.

We are very happy to welcome 3 new great Eligonauts to the team: • Ruth Keary from Ireland • Zack Hobbs from the USA and • Marie Rouquette from France!

Very proud and honoured to have Aurélie and Olivier join the Eligo team!
--
We look forward to their unique and comprehensive expertise as we grow the organization to best position our programs for the clinic and pursue strategic opportunities to strengthen our pipeline. Their collective experience will be invaluable as we execute on our strategy to discover and develop next-wave microbiome precision medicines for patients with diseases for which limited treatment options currently exist.

Eligo Bioscience strengthens its leadership and development team Eligo Bioscience strengthens its leadership and development team

[JOB OFFERS] , , and 🚀🦠
-- We are hiring a new cohort of amazing talents to join our international team of Eligonauts in Paris to work on one of the most exciting phage engineering platform!

Eligo Bioscience | Careers Eligo Bioscience | Careers

� We are hiring again!!!
>> Looking for the best patent engineer to join us at Eligo and work with our fantastic Head of IP Michèle Paquier!
We have some really exciting inventions cooking :)

https://eligo.bio/careers-patent-engineer/

Our CEO interviewed on BFM Business last Tuesday!

La face B de... Xavier Duportet - 28/05 Tous les soirs, votre nouveau rendez-vous s’intéresse à la face B des chefs d’entreprises ou des entrepreneurs. Ceux qui font bouger les lignes. Qui sont-ils ? Qu’est-ce qui les inspire ? D’où vient cette envie de changer les choses ? Ce mardi 28 mai 2019, Xavier Duportet, fondateur d'Eli...

👀 Nous sommes à la recherche d'une perle rare pour Eligo! 🦸‍♀️🦸🏼‍♂️🚀
🗣 N'hésitez pas à faire passer le message!

❗️Candidature en ligne uniquement ❗️

Eligo Bioscience | Careers - Office Manager Eligo Bioscience | Careers - Office Manager

Fantastic news for Eligo! We have just been selected as one of the European deeptech champions and will receive a €2.75M SMEinstrument phase 2 grant from the European Commission! Thank you for your support!

Eligo is in the news!

Phage Therapy: Turning the Tables on Bacteria CRISPR is a double-edged sword. It evolved to help bacteria slay phages. But CRISPR components can also be engineered into phages, arming them against bacteria. Consequently, phage therapy says, “En garde!”